Lifesenz Cancer Research Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 28-10-2024
- Paid Up Capital ₹ 0.10 M
as on 28-10-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Lifesenz Cancer Research Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hanskumar Shah, Kaushik Shah, and Arindam Banerjee serve as directors at the Company.
- CIN/LLPIN
U74999MH2022PTC377707
- Company No.
377707
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lifesenz Cancer Research Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanskumar Shah  | Director | 28-Feb-2022 | Current |
| Kaushik Shah | Director | 28-Feb-2022 | Current |
| Arindam Banerjee | Director | 28-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Lifesenz Cancer Research Labs.
Lifesenz Cancer Research Labs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Lifesenz Cancer Research Labs?
Unlock access to Lifesenz Cancer Research Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hemant Surgical Industries LimitedActive 35 years 8 monthsHanskumar Shah and Kaushik Shah are mutual person
- Ikigai Medequipments Private LimitedActive 3 years 9 months
Hanskumar Shah and Kaushik Shah are mutual person
- Ikigai Services Private LimitedActive 3 years 9 months
Hanskumar Shah and Kaushik Shah are mutual person
- Millennium Industries Private LimitedActive 28 years 11 months
Hanskumar Shah and Kaushik Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lifesenz Cancer Research Labs?
Lifesenz Cancer Research Labs has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifesenz Cancer Research Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifesenz Cancer Research Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
